Varma Mutual Pension Insurance Co Purchases 9,100 Shares of GE HealthCare Technologies Inc. $GEHC

Varma Mutual Pension Insurance Co lifted its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 9.0% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 110,400 shares of the company’s stock after acquiring an additional 9,100 shares during the period. Varma Mutual Pension Insurance Co’s holdings in GE HealthCare Technologies were worth $8,291,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds also recently added to or reduced their stakes in the company. True North Advisors LLC lifted its position in GE HealthCare Technologies by 2.0% in the 3rd quarter. True North Advisors LLC now owns 6,987 shares of the company’s stock valued at $525,000 after acquiring an additional 139 shares in the last quarter. Klingman & Associates LLC raised its stake in shares of GE HealthCare Technologies by 4.0% in the third quarter. Klingman & Associates LLC now owns 3,634 shares of the company’s stock worth $273,000 after purchasing an additional 139 shares during the last quarter. Golden State Wealth Management LLC lifted its holdings in shares of GE HealthCare Technologies by 7.4% during the second quarter. Golden State Wealth Management LLC now owns 2,138 shares of the company’s stock valued at $158,000 after purchasing an additional 148 shares in the last quarter. Exchange Traded Concepts LLC boosted its position in shares of GE HealthCare Technologies by 1.3% during the third quarter. Exchange Traded Concepts LLC now owns 11,490 shares of the company’s stock valued at $863,000 after buying an additional 150 shares during the last quarter. Finally, Modera Wealth Management LLC increased its holdings in GE HealthCare Technologies by 3.5% in the 2nd quarter. Modera Wealth Management LLC now owns 4,500 shares of the company’s stock worth $333,000 after buying an additional 152 shares in the last quarter. 82.06% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several research firms have issued reports on GEHC. Evercore upped their target price on shares of GE HealthCare Technologies from $95.00 to $98.00 and gave the company an “outperform” rating in a research note on Thursday, February 5th. Wells Fargo & Company increased their price objective on shares of GE HealthCare Technologies from $95.00 to $97.00 and gave the company an “overweight” rating in a research report on Thursday, February 5th. Bank of America lifted their target price on shares of GE HealthCare Technologies from $82.00 to $92.00 and gave the stock a “neutral” rating in a research report on Monday, January 5th. Weiss Ratings reiterated a “hold (c+)” rating on shares of GE HealthCare Technologies in a research note on Monday, December 29th. Finally, Stifel Nicolaus raised their price target on GE HealthCare Technologies from $95.00 to $98.00 and gave the stock a “buy” rating in a research note on Wednesday, February 4th. Seven analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $92.50.

GE HealthCare Technologies Stock Up 2.1%

Shares of GEHC stock opened at $80.34 on Friday. The company has a current ratio of 1.37, a quick ratio of 1.13 and a debt-to-equity ratio of 0.91. GE HealthCare Technologies Inc. has a 12 month low of $57.65 and a 12 month high of $93.26. The stock has a market cap of $36.61 billion, a P/E ratio of 17.62, a P/E/G ratio of 1.73 and a beta of 1.08. The company has a 50 day simple moving average of $82.44 and a two-hundred day simple moving average of $77.62.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings data on Wednesday, February 4th. The company reported $1.44 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.40 by $0.04. GE HealthCare Technologies had a net margin of 10.11% and a return on equity of 21.35%. The firm had revenue of $5.70 billion during the quarter, compared to the consensus estimate of $5.60 billion. During the same quarter in the previous year, the firm posted $1.45 EPS. The company’s revenue for the quarter was up 7.1% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. On average, research analysts expect that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, May 15th. Stockholders of record on Friday, April 3rd will be paid a $0.035 dividend. The ex-dividend date of this dividend is Thursday, April 2nd. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio (DPR) is 3.07%.

GE HealthCare Technologies Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.